Allopurinol treatment reduces arterial wave reflection in stroke survivors

Cardiovascular Therapeutics

Volumn 26, Issue 4, 2008, Pages 247-252

  Khan, Faisel ^a   George, Jacob ^a   Wong, Kenneth ^a   McSwiggan, Stephen ^a   Struthers, Allan D ^a   Belch, Jill J F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Arterial wave reflection; Oxidative stress; Stroke; Uric acid; Xanthine oxidase

Indexed keywords

ALLOPURINOL; PLACEBO; URATE; XANTHINE OXIDASE;

ADULT; AGED; ARTICLE; AUGMENTATION INDEX; BLOOD VESSEL FUNCTION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DOUBLE BLIND PROCEDURE; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; MORBIDITY; MORTALITY; PILOT STUDY; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; STROKE; VALIDATION PROCESS;

AGED; ALLOPURINOL; ANTIOXIDANTS; ARTERIES; BLOOD PRESSURE; DOUBLE-BLIND METHOD; ELASTICITY; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; STROKE; SURVIVORS; URIC ACID; XANTHINE OXIDASE;

EID: 55849104900     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2008.00057.x     Document Type: Article

References (30)

1. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000 283 : 2404 2410.
2. Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, Balonen JT. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study. Arch Intern Med 2004 164 : 1546 1551.
3. Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us? Am J Med 2005 118 : 816 826.
4. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death. Ann Intern Med 1999 131 : 7 13.
5. George J, Struthers AD. The role of urate and xanthine oxidase inhibitors in cardiovascular disease. Cardiovasc Drug Rev 2008 26 : 59 64.
6. Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002 106 : 221 226.
7. George J, Carr E, Davies J, Belch JJF, Struthers A. High dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006 114 : 2508 2516.
8. Dennis MS BJ, Sandercock PA, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: The Oxfordshire Community Stroke Project. Stroke 1993 24 : 796 800.
9. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 1997 95 : 1827 1836.
10. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, Eber B. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004 109 : 184 189.
11. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 2000 525 (Pt 1) : 263 270.
12. Wykretowicz A, Guzik P, Kasinowski R, Krauze T, Bartkowiak G, Dziarmaga M, Wysocki H. Augmentation index, pulse pressure amplification and superoxide anion production in patients with coronary artery disease. Int J Cardiol 2005 99 : 289 294.
13. McLeod AL, Uren NG, Wilkinson IB, Webb DJ, Maxwell SR, Northridge DB, Newby DE. Non-invasive measures of pulse wave velocity correlate with coronary arterial plaque load in humans. J Hypertens 2004 22 : 363 368.
14. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study. Hypertension 2002 39 : 10 15.
15. Gatzka CD, Cameron JD, Kingwell BA, Dart AM. Relation between coronary artery disease, aortic stiffness, and left ventricular structure in a population sample. Hypertension 1998 32 : 575 578.
16. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998 32 : 570 574.
17. Mallareddy M, Parikh CR, Peixoto AJ. Effect of angiotensin-converting enzyme inhibitors on arterial stiffness in hypertension: Systematic review and meta-analysis. J Clin Hypertens (Greenwich) 2006 8 : 398 403.
18. Hozawa A, Folsom AR, Ibrahim H, Nieto JF, Rosamond WD, Shahar E. Serum uric acid and risk of ischemic stroke: The ARIC Study. Atherosclerosis 2006 187 : 401 407.
19. Milionis HJ, Kalantzi KJ, Goudevenos JA, Seferiadis K, Mikhailidis DP, Elisaf MS. Serum uric acid levels and risk for acute ischaemic non-embolic stroke in elderly subjects. J Intern Med 2005 258 : 435 441.
20. Wong KY, MacWalter RS, Fraser HW, Crombie I, Ogston SA, Struthers AD. Urate predicts subsequent cardiac death in stroke survivors. Eur Heart J 2002 23 : 788 793.
21. Weir CJ, Muir SW, Walters MR, Lees KR. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003 34 : 1951 1956.
22. Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, Rosano GM. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004 94 : 932 935.
23. Baldus S, Koster R, Chumley P, Heitzer T, Rudolph V, Ostad MA, Wammoltz A, Staude HJ, Thuneke K, Koss K, et al. Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med 2005 39 : 1184 1190.
24. Butler R, Morris AD, Belch JJ, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000 35 : 746 751.
25. Waring WS, McKnight JA, Webb DJ, Maxwell SR. Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes 2006 55 : 3127 3123.
26. Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, Uz E, Akcay A, Yigitoglu R, Covic A. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol 2007 39 : 1227 1233.
27. Kullo IJ, Seward JB, Bailey KR, Bielak LF, Grossardt BR, Sheedy PF, Peysor P, Turner S. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens 2005 18 : 1123 1129.
28. Kielstein JT, Donnerstag F, Gasper S, Menne J, Kielstein A, Martens-Lobenhoffer J, Scalera F, Cooke JP, Fliser D, Bode-Böger SM. ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke 2006 37 : 2024 2029.
29. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001 38 : 434 438.
30. Coviv A, Haydar AA, Bhamra Ariza P, Taomir-Gusbeth P, Goldsmith DJ. Aortic pulse wave velocity and arterial wave reflection predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol 2005 18 (4 388 396.